This versatility allows for effective creation of customized medicines, as manufacturers can adapt quickly to switching therapy demands and deliver smaller sized quantities devoid of compromising cost-performance.“It makes it difficult to advise that bringing the many API manufacturing back again for the US and Europe solves the issue. It doesn�